Aberrant c-Abl activity has been implicated in PD pathogenesis [13–18], and pharmacological inhibition of c-Abl has been shown to be neuroprotective in diverse PD animal models, including that of virally induced PARIS brain expression [12, 19, 20]. This evidence concerns the gene ABL1 and Parkinson disease.